Activation and role of astrocytes in ischemic stroke

XY Shen, ZK Gao, Y Han, M Yuan, YS Guo… - Frontiers in cellular …, 2021 - frontiersin.org
Ischemic stroke refers to the disorder of blood supply of local brain tissue caused by various
reasons. It has high morbidity and mortality worldwide. Astrocytes are the most abundant …

Apoptosis and acute brain ischemia in ischemic stroke

D Radak, N Katsiki, I Resanovic… - Current vascular …, 2017 - ingentaconnect.com
Apoptosis may contribute to a significant proportion of neuron death following acute brain
ischemia (ABI), but the underlying mechanisms are still not fully understood. Brain ischemia …

[HTML][HTML] PCSK9 inhibitors: a new era of lipid lowering therapy

R Chaudhary, J Garg, N Shah… - World journal of …, 2017 - ncbi.nlm.nih.gov
Hyperlipidemia is a well-established risk factor for developing cardiovascular disease
(CVD). The recent American College of Cardiology and American Heart Association …

Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial

CS Robertson, HJ Hannay, JM Yamal, S Gopinath… - Jama, 2014 - jamanetwork.com
Importance There is limited information about the effect of erythropoietin or a high
hemoglobin transfusion threshold after a traumatic brain injury. Objective To compare the …

More insight into BDNF against neurodegeneration: anti-apoptosis, anti-oxidation, and suppression of autophagy

SD Chen, CL Wu, WC Hwang, DI Yang - International journal of molecular …, 2017 - mdpi.com
In addition to its well-established neurotrophic action, brain-derived neurotrophic factor
(BDNF) also possesses other neuroprotective effects including anti-apoptosis, anti …

The transforming growth factor-β superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury

T Kempf, M Eden, J Strelau, M Naguib… - Circulation …, 2006 - Am Heart Assoc
Data from the Women's Health Study show that serum levels of growth-differentiation factor-
15 (GDF-15), a distant member of the transforming growth factor-β superfamily, are an …

Pathophysiology and pharmacologic treatment of acute spinal cord injury

BK Kwon, W Tetzlaff, JN Grauer, J Beiner, AR Vaccaro - The spine journal, 2004 - Elsevier
BACKGROUND CONTEXT: The past three decades have witnessed increasing interest in
strategies to improve neurologic function after spinal cord injury. As progress is made in our …

Functional hypoxia drives neuroplasticity and neurogenesis via brain erythropoietin

D Wakhloo, F Scharkowski, Y Curto… - Nature …, 2020 - nature.com
Erythropoietin (EPO), named after its role in hematopoiesis, is also expressed in mammalian
brain. In clinical settings, recombinant EPO treatment has revealed a remarkable …

[HTML][HTML] Recent advances in nanomedicines for the treatment of ischemic stroke

C Li, T Sun, C Jiang - Acta Pharmaceutica Sinica B, 2021 - Elsevier
Ischemic stroke is a cerebrovascular disease normally caused by interrupted blood supply to
the brain. Ischemia would initiate the cascade reaction consisted of multiple biochemical …

Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use

U Dirnagl, K Becker, A Meisel - The Lancet Neurology, 2009 - thelancet.com
Neuroprotection and brain repair in patients after acute brain damage are still major
unfulfilled medical needs. Pharmacological treatments are either ineffective or confounded …